Red Light Therapy for Myopia—Current Regulatory Changes in China
This Viewpoint discusses the ophthalmic device, red light therapy, for myopia treatment in children and adolescents in China, including its development and use, safety concerns, and implications surrounding recent regulatory changes and reclassification of this device.
Authors
- Ningli Wang (ORCID: https://orcid.org/0000-0002-8933-4482)
- Ya Xing Wang
- Tien Yin Wong (ORCID: https://orcid.org/0000-0002-8448-1264)
Institutions
- Beijing Tongren Hospital (CN)
- Capital Medical University (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2025-01-23
- DOI
- https://doi.org/10.1001/jamaophthalmol.2024.5977
- Citations
- 11
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 14.90